Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fish and Richardson
Deloitte
Medtronic
Federal Trade Commission
Farmers Insurance
McKesson
Colorcon
Cantor Fitzgerald
Chinese Patent Office

Generated: February 24, 2018

DrugPatentWatch Database Preview

Auxilium Pharms Llc Company Profile

« Back to Dashboard

What is the competitive landscape for AUXILIUM PHARMS LLC, and what generic alternatives to AUXILIUM PHARMS LLC drugs are available?

AUXILIUM PHARMS LLC has nine approved drugs.

There are eleven US patents protecting AUXILIUM PHARMS LLC drugs.

There are one hundred and seventeen patent family members on AUXILIUM PHARMS LLC drugs in thirty-eight countries.

Summary for Auxilium Pharms Llc
International Patents:117
US Patents:11
Tradenames:9
Ingredients:7
NDAs:9

Drugs and US Patents for Auxilium Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-001 Jun 12, 1997 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 AB2 RX Yes Yes 7,608,609 ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 AB2 RX Yes Yes 7,608,605 ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-004 Jun 12, 1997 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 AB2 RX Yes Yes 7,608,608 ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc THEO-24 theophylline CAPSULE, EXTENDED RELEASE;ORAL 087943-001 Aug 22, 1983 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc EDEX alprostadil INJECTABLE;INJECTION 020649-002 Jun 12, 1997 AP RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 AB2 RX Yes Yes 7,608,607 ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 AB2 RX Yes Yes 7,608,606 ➤ Try a Free Trial ➤ Try a Free Trial
Auxilium Pharms Llc STRIANT testosterone TABLET, EXTENDED RELEASE;BUCCAL 021543-001 Jun 19, 2003 RX Yes Yes 6,248,358 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Auxilium Pharms Llc

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Auxilium Pharms Llc SEMPREX-D acrivastine; pseudoephedrine hydrochloride CAPSULE;ORAL 019806-001 Mar 25, 1994 4,501,893 ➤ Try a Free Trial
Auxilium Pharms Llc STRIANT testosterone TABLET, EXTENDED RELEASE;BUCCAL 021543-001 Jun 19, 2003 4,615,697 ➤ Try a Free Trial
Auxilium Pharms Llc SEMPREX-D acrivastine; pseudoephedrine hydrochloride CAPSULE;ORAL 019806-001 Mar 25, 1994 4,650,807 ➤ Try a Free Trial
Auxilium Pharms Llc TESTIM testosterone GEL;TRANSDERMAL 021454-001 Oct 31, 2002 5,023,252 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for AUXILIUM PHARMS LLC drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Gel 1% ➤ Subscribe 8/21/2008

Non-Orange Book US Patents for Auxilium Pharms Llc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,126,959 Pharmaceutical composition for treating dysmenorrhea and premature labor ➤ Try a Free Trial
7,153,845 Bioadhesive progressive hydration tablets ➤ Try a Free Trial
8,765,177 Bioadhesive progressive hydration tablets ➤ Try a Free Trial
6,624,200 Bioadhesive progressive hydration tablets ➤ Try a Free Trial
6,699,494 Pharmaceutical composition and method for treating premature labor ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for Auxilium Pharms Llc Drugs

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Express Scripts
Federal Trade Commission
Daiichi Sankyo
McKesson
Chubb
Deloitte
US Department of Justice
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot